A look at the weighted underlying holdings of the Invesco S&P SmallCap Low Volatility ETF (XSLV) shows an impressive 14.4% of holdings on a weighted basis have experienced insider buying within the past six months.
Community Healthcare Trust Inc (Symbol: CHCT), which makes up 0.91% of the Invesco S&P SmallCap Low Volatility ETF (XSLV), has seen 4 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $4,570,094 worth of CHCT, making it the #42 largest holding. The table below details the recent insider buying activity observed at CHCT:
CHCT — last trade: $35.97 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 03/10/2023 | R. Lawrence Van Horn | Director | 685 | $36.43 | $24,955 |
| 03/10/2023 | Cathrine Cotman | Director | 277 | $36.24 | $10,038 |
| 03/09/2023 | Alan Gardner | Director | 2,700 | $36.74 | $99,198 |
| 03/09/2023 | Claire M. Gulmi | Director | 2,042 | $36.77 | $75,084 |
And Southside Bancshares, Inc. (Symbol: SBSI), the #43 largest holding among components of the Invesco S&P SmallCap Low Volatility ETF (XSLV), shows 4 directors and officers as recently filing Form 4’s indicating purchases. The ETF holds $4,551,369 worth of SBSI, which represents approximately 0.91% of the ETF’s total assets at last check. The recent insider buying activity observed at SBSI is detailed in the table below:
SBSI — last trade: $32.29 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 10/26/2022 | Susan Elaine Anderson | Director | 2,000 | $31.36 | $62,720 |
| 10/27/2022 | Lee R. Gibson | PRES & CEO | 2,000 | $33.22 | $66,440 |
| 10/31/2022 | John F. Sammons Jr. | Director | 500 | $34.52 | $17,260 |
| 01/31/2023 | Herbert C. Buie | Director | 2,380 | $37.23 | $88,607 |
10 ETFs With Stocks That Insiders Are Buying »
Also see:
Steven Cohen Stock Picks
OSW market cap history
ALKS YTD Return
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
